Microorganisms, Volume 14, Issue 1
2026 January - 261 articles
Cover Story: Human milk oligosaccharides (HMOs) are best known for shaping the infant gut microbiome but may also act in a region-specific manner along the gastrointestinal tract. This review follows HMOs from the oral cavity—where they can hinder pathogen adhesion and biofilm formation—to the stomach, where fucosylated and sialylated HMOs may serve as soluble decoy receptors against Helicobacter pylori. In the small intestine, HMOs support epithelial integrity and immune balance. Reaching the colon largely intact, they selectively nourish beneficial microbes, increase short-chain fatty acid production through cross-feeding, and reinforce barrier function. These multi-site mechanisms position HMOs as promising functional glycans for gut health beyond infancy, including in adults, while highlighting the need for well-designed clinical trials. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.